Up - regulated expression of zonula occludens protein - 1 in
human melanoma associates with N - cadherin and contributes to invasion and adhesion.
Not exact matches
In a series of studies led by Dr. Arun Sharma,
associate professor of pharmacology and Dr. Shantu Amin, professor of pharmacology, both of Penn State College of Medicine, researchers designed and synthesized a compound called napthalamide - isoselenocyanate — NISC - 6 — to inhibit both the Akt1 pathway and
human topoisomerase IIα — topo IIα — activity, which contribute to
melanoma tumor growth.
The analysis also found that a significant fraction of tumors contained rearrangements and mutations of a gene called PREX2, and experiments confirmed that cancer -
associated mutations of PREX2 promoted the growth of
human melanoma cells in mice.
Over 50
human genomic loci are
associated with either pigmentation phenotypes or
melanoma susceptibility.
Both mutations affect the function of CDKN2A, a tumor suppressor gene
associated with
melanoma in
humans.
Melanoma is a classical skin cancer of
humans, and in
humans it is
associated with sun exposure.